期刊文献+

黄芪对心肌成纤维细胞增殖及分泌转化生长因子-β_1的影响 被引量:11

Effects of Astragalus membranaous on the proliferation and transforming growth factor β_1 production of cardiac fibroblasts
下载PDF
导出
摘要 目的观察黄芪注射液对血管紧张素Ⅱ(AngⅡ)诱导的心肌成纤维细胞分泌转化生长因子(TGF-β1)的影响。方法体外培养乳鼠心脏成纤维细胞并制成单细胞悬液,分为对照组,黄芪低、中、高剂量组,AngⅡ组,AngⅡ联合黄芪低、中、高剂量组,分别加入50、100、200 mg/ml黄芪注射液,以及10-7 mol/L AngⅡ,共同培育2 d。用四甲基偶氮哇盐法测定各组细胞增殖情况,ELISA法测定培养上清TGF-β1分泌情况。结果各组间细胞增殖率差异有统计学意义(F=71.84,P=0.000);AngⅡ组的细胞增殖率明显升高,与其余各组比较均有统计学意义(P均<0.05);AngⅡ联合黄芪后,随着黄芪剂量的逐渐增加,细胞增殖率逐渐下降,差异均有统计学意义(P<0.05)。各组间TGF-β1分泌量差异也有统计学意义(F=786.81,P=0.000);黄芪低、中、高剂量组的TGF-β1分泌量均低于对照组,差异有统计学意义(P均<0.05);AngⅡ组的TGF-β1分泌量为各组中最高,与其余各组比较均有统计学意义(P均<0.05);AngⅡ联合黄芪后,随着黄芪剂量的逐渐增加,TGF-β1分泌量逐渐下降,差异均有统计学意义(P<0.05)。结论 AngⅡ可刺激心肌成纤维细胞增殖,促进心肌成纤维细胞分泌TGF-β1,而黄芪注射液可明显抑制AngⅡ诱导心肌成纤维细胞的增殖作用,并且减少心肌成纤维细胞分泌TGF-β1。 Objective To observe the effect of Astragalus membranaous on angiotensin Ⅱ(Ang Ⅱ)-induced transforming growth factor β1(TGF-β1) production of cardiac fibroblasts.Methods Cardiac fibroblasts were cultured in vitro.Cells were allocated into 3 groups:control group,Astragalus membranaous groups(50,100,200 mg/ml),Ang II group(10-7 mol/L) and Ang Ⅱ /Astragalus membranaous groups(50,100,200 mg/ml).The proliferation of each group was tested by methyl thiazolyl tetrazolium method.TGF-β1 was measured by ELISA.Results The proliferation of cardiac fibroblasts had significant difference between each groups(F=71.84,P=0.000).The proliferation of cardiac fibroblasts with Ang II stimulation was higher than that of cells without Ang II stimulation(P〈0.05).Astragalus membranaous inhibited Ang II-induced cardiac fibroblasts proliferation dose dependently(P〈0.05).The TGF-β1 production had significant difference between each groups(F=786.81,P=0.000).The TGF-β1 production in Ang II/astragalus membranaous groups was lower than that in Ang II group(P〈0.05).The TGF-β1 production in Ang II group was the highest,and had significant difference as compared to other groups(P〈0.05).Astragalus membranaous inhibited Ang II-induced TGF-β1 production dose dependently(P〈0.05).Conclusions Ang II can stimulate the proliferation of cardiac fibroblasts,and promote the TGF-β1 production.Astragalus membranaous can inhibit the proliferation of Ang II-induced cardiac fibroblasts,and reduce the TGF-β1 production of cardiac fibroblasts.
出处 《临床儿科杂志》 CAS CSCD 北大核心 2015年第3期284-286,共3页 Journal of Clinical Pediatrics
基金 湖南省教育厅科研基金资助项目(No.13C522) 湖南省中医药科研计划项目(No.2014105)
关键词 黄芪 血管紧张素Ⅱ 心脏成纤维细胞 转化生长因子Β1 体外研究 Astragalus membranaou angiotensin Ⅱ cardiac fibroblasts transforming growth factor β1 in vitro
  • 相关文献

参考文献7

  • 1Leask A. Potential therapeutic targets for cardiac fibro-sis:TGF-beta, angiotension, endothelin, CCN2, and PDGF, partners in fibroblast activation [J]. Cire Res, 2010, 106(11). 1675-1680.
  • 2周贤,戴立里,贾丽萍,郑元义,王文兵.黄芪注射液对肝纤维化抑制作用的实验研究[J].中华肝脏病杂志,2005,13(8):575-578. 被引量:34
  • 3Sun L, Jin H, Sun L, et al Hydrogen sulfide alleviates myocardial collagen remodeling in association with inhibi-tion of TGF-beta/smad signaling pathway in spontaneously hypertensive rats [J]. Mol Med, 2014, Sep10.doi:10.2199/molmed. 2013.00096.
  • 4Ferrer E, Peinado VI, Castaneda J, et al. Effects of ciga-rette smoke and hypoxia on pulmonary circulation in the guinea pig [J]. Eur Respir, 2011, 38(3):617-627.
  • 5Yang F, Chung AC, Huang XR, et al. Angiotensin Ⅱ in-duces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and-independent Smad pathways:the role of Smad3 [J]. Hypertension, 2009, 54(4):877-884.
  • 6袁勇华,何学华,方亦兵.卡维地洛和黄芪对扩张型心肌病大鼠心功能影响的对比观察[J].临床儿科杂志,2011,29(7):670-673. 被引量:6
  • 7杨溶海,方长庚,王俊容.参芪扶正注射液联合磷酸肌酸治疗慢性心力衰竭的临床观察[J].河北医药,2010,32(9):1111-1112. 被引量:13

二级参考文献16

  • 1邢桂平,聂秀敏.黄芪注射液对充血性心力衰竭患者血流动力学的影响[J].中国医药导报,2006,3(11):67-68. 被引量:9
  • 2李彬.磷酸肌酸钠治疗充血性心力衰竭的临床观察[J].实用心脑肺血管病杂志,2006,14(7):556-557. 被引量:37
  • 3赵悦如.多普勒测试党参口服液对冠心病心功能改善的研究[J].北京中医药大学学报,1996,19(3):49-49. 被引量:25
  • 4Shah HR, Vaynblat M, Ramdev G. et al. Experimental cardiomyopathy as a model of chronic heart failure [J]. Invest Surg,1997,10(6) :387-396.
  • 5Chua S, Shen JJ, Chang LT, et al. Comparison of losartan and carvedilol on attenuating inflammatory and oxidative response and preserving energy transcription factors and left ventricular function in dilated cardiomyopathy rats [J].Int Heart J,2008,49(5):605-619.
  • 6Li ZP, Cao Q. Effects of astragaloside Ⅳ on myocardial collagen and cardiac function of ischemic rats [J]. Acta Pharmacol Sin 2002,23 (10) : 898-904.
  • 7Askari H, Semizel E, Bostan OM. et al. Carvedilol therapy in pediatric patients with dilated cardiomyopathy [J], Turk J Pediatr,2009,51 ( 1 ) :22-27.
  • 8Capomolla S, Febo O, Gnemmi M, et al. β-blockade therapy in chronic heart failure diastolic function and mitral regurgitation improvement by carvedilol [J]. Am Heart J ,2000,139(4) :596'--608.
  • 9Xu XL, Ji H, Gu SY, et al. Modification of alterations in cardiac function and sarcoplsmic reticulum by astragaloside Ⅲ in myocardial injury in vivo [J]. Eur J Pharmacol, 2007,568 ( 1-3 ) : 203-212.
  • 10Zhang C, Wang XH, Zhong MF, et al. Mechanisms underling vasorelaxant action of astragaloside IV in isolated rat aortic rings [J]. Clin Exp Pharmacol Physiol,2007,34 (5-6) :387-392.

共引文献50

同被引文献230

引证文献11

二级引证文献237

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部